VC23 Investors
Venture capitalAvon · Seed–Series A · 6 people tracked
Find your way into VC23 Investors
Each arrow is one introduction. Sign up to fill in the first one.
Ask Andrew Vaz to introduce you to Parag Jhaveri
You →Andrew · together at Voicecare →Parag
Ask Jamie Chen to introduce you to Nat Brinn
You →Jamie · together at The Phoenix Companies →Nat
Ask Sam Okafor to introduce you to Ralph Vossmeyer
You →Sam · together at OpenCorporates →Ralph
Sign up to find every way you can get introduced to VC23 Investors
- Your email: who you already know at VC23 Investors, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the VC23 Investors team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
VC23 invests across sectors but concentrates on BioTools, arguing these companies scale faster and more capital-efficiently than therapeutics, reach revenue and partnerships earlier, and require less capital before exit while attracting steady acquisition interest from incumbents. The firm believes the convergence of compute, AI, and biology creates a multiplicative innovation feedback loop enabling faster drug discovery, scalable synthetic biology, and precision diagnostics. It applies deep technical and commercial diligence and uses AI-enhanced tools to uncover value others might miss, supported by Venture Partners who invest alongside the firm and provide operational expertise to portfolio companies.
Source: firm website, verified Aug 3, 2026.
Team · 6 people
from public directoriesFrequently asked questions
- What stage does VC23 Investors invest at?
- VC23 Investors invests at the Seed, Series A stages.
- What sectors does VC23 Investors focus on?
- VC23 Investors focuses on AI & Machine Learning, Biotech, Healthtech, Medical Devices.
- Where is VC23 Investors located?
- VC23 Investors is headquartered in Avon, US.
Images
Similar investors
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Breyer Capital is a venture capital firm that backs high-impact entrepreneurs, making strategic investments guided by founder passion and its network of experienced investors.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.








.jpeg)
